Clinical Trial Update: A Prospective Cohort Study on Drug-induced Liver Injury in China（DILI-P）

View source ↗

Summary

A prospective cohort study in China (DILI-P) is currently recruiting to investigate drug-induced liver injury (DILI).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-induced Liver Injury

Snippet

Sponsor: Drug Induced Liver Disease Study Group | Conditions: Drug-induced Liver Injury | Status: RECRUITING